RegimenMD: The Amazon Of Dermatology?
Executive Summary
Top executives from the pharmaceutical industry and direct-to-consumer marketing are teaming up with leading dermatologists and manufacturers of skin-care products to create RegimenMD, a new hybrid business model that is part bricks-and-mortar, part Internet-based and completely in tune with the times.
You may also be interested in...
Skin Is In With Biomedical Investors
Unique market dynamics and plenty of exit options are attracting investors to dermatology. Profiles of Aclaris Therapeutics, Alexar Therapeutics, Rogne Bioscience, and Scioderm.
Super-Specialist CROs: Commercializing Pharma R&D Expertise
Outsourcing is not just for mundane pharma services anymore. Increasingly, drugmakers are contracting for specialized R&D assistance they expect to provide strategic as well as tactical advantages.
Spero Therapeutics: Remodeling Antibiotics
Like other companies investigating entirely new ways of treating bacterial infections, biotech start-up Spero is increasingly aware that novel antibiotics may need to travel new clinical and regulatory pathways to market.